RIGEL PHARMACEUTICALS INC - Common Stock (RIGL)
CUSIP: 766559702
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 18,187,050
- Total 13F shares
- 14,989,035
- Share change
- +1,065,128
- Total reported value
- $424,666,568
- Put/Call ratio
- 69%
- Price per share
- $28.33
- Number of holders
- 164
- Value change
- +$32,448,563
- Number of buys
- 101
- Number of sells
- 54
Quarterly Holders Quick Answers
What is CUSIP 766559702?
CUSIP 766559702 identifies RIGL - RIGEL PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 766559702:
Top shareholders of RIGL - RIGEL PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.7%
from 13D/G
|
1,625,770
|
$30,450,672 | — | 30 Jun 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
13D/G
|
Company |
4%
from 13D/G
|
1,600,000
|
$29,968,000 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
13D/G
|
Company |
0.7%
from 13D/G
|
1,520,217
|
$28,473,666 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.8%
|
1,052,871
|
$19,720,274 | — | 30 Jun 2025 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
3.6%
|
658,145
|
$12,327,056 | — | 30 Jun 2025 | |
| Soleus Capital Master Fund, L.P. |
13D/G
|
— |
3.7%
|
658,145
|
$12,327,056 | -$8,850,562 | 30 Jun 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
3.4%
|
623,004
|
$11,664,000 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.3%
|
600,181
|
$11,241,390 | — | 30 Jun 2025 | |
| Capitolis Liquid Global Markets LLC |
13F
|
Company |
3.3%
|
591,553
|
$11,079,788 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
415,607
|
$7,785,775 | — | 30 Jun 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
2%
|
368,950
|
$6,910,434 | — | 30 Jun 2025 | |
| Hillsdale Investment Management Inc. |
13F
|
Company |
1.4%
|
262,064
|
$4,908,459 | — | 30 Jun 2025 | |
| CM Management, LLC |
13F
|
Company |
1.4%
|
250,000
|
$4,682,500 | — | 30 Jun 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
1.3%
|
240,005
|
$4,495,294 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.3%
|
236,446
|
$4,428,634 | — | 30 Jun 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1.2%
|
215,633
|
$4,038,806 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1%
|
187,621
|
$3,514,141 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1%
|
182,249
|
$3,413,524 | — | 30 Jun 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.94%
|
171,424
|
$3,210,772 | — | 30 Jun 2025 | |
| GLOBEFLEX CAPITAL L P |
13F
|
Company |
0.92%
|
167,515
|
$3,137,556 | — | 30 Jun 2025 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.86%
|
157,000
|
$2,940,000 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.85%
|
155,021
|
$2,904,596 | — | 30 Jun 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.81%
|
148,183
|
$2,775,468 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.75%
|
136,496
|
$2,556,570 | — | 30 Jun 2025 | |
| ZACKS INVESTMENT MANAGEMENT |
13F
|
Company |
0.75%
|
135,845
|
$2,544,386 | — | 30 Jun 2025 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.58%
|
104,890
|
$1,964,590 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.57%
|
103,267
|
$1,934,191 | — | 30 Jun 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.54%
|
98,844
|
$1,851,348 | — | 30 Jun 2025 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
0.53%
|
95,700
|
$1,792,000 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.51%
|
93,035
|
$1,742,547 | — | 30 Jun 2025 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.51%
|
92,677
|
$1,735,840 | — | 30 Jun 2025 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.45%
|
82,348
|
$1,542,378 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.43%
|
77,491
|
$1,451,406 | — | 30 Jun 2025 | |
| Brandywine Global Investment Management, LLC |
13F
|
Company |
0.42%
|
76,870
|
$1,439,775 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.37%
|
68,056
|
$1,274,689 | — | 30 Jun 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.35%
|
63,820
|
$1,195,348 | — | 30 Jun 2025 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.35%
|
63,458
|
$1,188,568 | — | 30 Jun 2025 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.33%
|
59,827
|
$1,120,560 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.33%
|
59,806
|
$1,120,167 | — | 30 Jun 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.28%
|
51,133
|
$957,721 | — | 30 Jun 2025 | |
| Carrera Capital Advisors |
13F
|
Company |
0.28%
|
50,299
|
$942,100 | — | 30 Jun 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.23%
|
40,921
|
$766,000 | — | 30 Jun 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.21%
|
38,342
|
$718,146 | — | 30 Jun 2025 | |
| MACKENZIE FINANCIAL CORP |
13F
|
Company |
0.21%
|
37,827
|
$708,500 | — | 30 Jun 2025 | |
| SIERRA SUMMIT ADVISORS LLC |
13F
|
Company |
0.2%
|
37,269
|
$698,049 | — | 30 Jun 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.2%
|
36,215
|
$678,307 | — | 30 Jun 2025 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
0.2%
|
36,001
|
$674,299 | — | 30 Jun 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
34,970
|
$654,988 | — | 30 Jun 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.17%
|
31,473
|
$589,489 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.17%
|
31,259
|
$585,481 | — | 30 Jun 2025 |
Institutional Holders of RIGEL PHARMACEUTICALS INC - Common Stock (RIGL) as of Q3 2025
As of 30 Sep 2025,
RIGEL PHARMACEUTICALS INC - Common Stock (RIGL) was held by
164 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,989,035 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, ARMISTICE CAPITAL, LLC, ACADIAN ASSET MANAGEMENT LLC, MARSHALL WACE, LLP, Capitolis Liquid Global Markets LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
164
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
121
Q3 2025 holders
164
Holder diff
43
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.